22 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel DiseaseDigestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorderRecruitingNot applicable2026-09-22NCT07582731
Advanced Adenoma Detection With 3D Imaging Device During Colonoscopycolorectal adenomaRecruitingNot applicable2026-08-18NCT06924489
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure TimeDigestive System Diseases, Digestive System Neoplasms, Hemorrhage, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorderRecruitingNot applicable2026-08-17NCT07401303
Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESDPatient ComplianceRecruitingNot applicable2026-08-17NCT06092281
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisActive, not recruitingEarly phase 12026-07-29NCT07104201
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)Acute Severe Ulcerative ColitisRecruitingPhase 42026-04-24NCT07550673
Optimization of taVNS Intervention Strategies for Refractory ConstipationPathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorderRecruitingNot applicable2026-01-15NCT07344402
Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom DisorderPathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorderRecruitingNot applicable2026-01-09NCT07323407
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World StudyDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 32026-01-08NCT06755541
Fenofibrate in Primary Biliary Cholangitis: a Real World StudyDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 32026-01-08NCT06755151
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary CholangitisDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 32026-01-08NCT05751967
Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary CholangitisDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 2 / Phase 32026-01-08NCT05749822
Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsiaanxiety, anxiety disorder, depressive disorder, psychiatric disorderRecruitingPhase 42026-01-05NCT07187492
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsiaanxiety, anxiety disorder, depressive disorder, psychiatric disorderRecruitingPhase 42026-01-05NCT07182890
FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 32025-12-29NCT07296458
The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBDDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisEnrolling by invitationNot applicable2025-12-02NCT07257588
Efficacy and Safety of Berberine for Gastric Intestinal Metaplasiagastric intestinal metaplasiaNot yet recruitingPhase 42025-09-04NCT07129460
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity EvaluationMedically Unexplained Symptoms, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorderRecruitingNot stated2025-07-24NCT06221722
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative ColitisDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitisRecruitingNot stated2025-07-03NCT06962020
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial TreatmentHelicobacter Pylori Infection Chronic GastritActive, not recruitingPhase 42025-07-03NCT06523764
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisRecruitingPhase 2 / Phase 32025-07-02NCT06365424
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric JunctionSiewert Type II Adenocarcinoma of Esophagogastric JunctionRecruitingNot applicable2024-11-08NCT05356520